NEW YORK, July 23, 2013 /PRNewswire/ --
Today, Investors' Reports announced new research reports
highlighting Covidien plc (NYSE: COV), C.R. Bard, Inc. (NYSE: BCR),
Mindray Medical International Limited (NYSE: MR), CareFusion
Corporation (NYSE: CFN), and DENTSPLY International Inc. (NASDAQ:
XRAY). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings
- via the links below.
Covidien plc Research Report
On July 17, 2013, Covidien plc
(Covidien) announced that the Company's Board of Directors has
declared a quarterly cash dividend of $0.26 per ordinary share. The dividend is payable
on August 15, 2013 to shareholders of
record as of the close of business on July
30, 2013. Covidien previously announced that it will report
its Q3 FY 2013 results on August 1,
2013 before trading begins, and hold a conference call for
investors at 8:30 a.m. ET on the same
day. The Full Research Report on Covidien plc - including full
detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-18/COV]
--
C.R. Bard, Inc. Research Report
On July 9, 2013, C.R. Bard, Inc.
(Bard) announced that it will host a conference call on
July 23, 2013 at 5:00 p.m. EDT, to discuss the Company's Q2 2013
operating results, as well as to provide financial guidance for Q3
2013. Bard informed that the earnings press release will be issued
on the same day, after the market closes. In Q1 2013, Bard reported
a 1% YoY increase in net sales, amounting to $740.3 million. Q1 2013 net income was
$90.7 million and diluted EPS was
$1.08, a decrease of 35% YoY and 33%
YoY, respectively. The Full Research Report on C.R. Bard, Inc. -
including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-18/BCR]
--
Mindray Medical International Limited
Research Report
On July 17, 2013, Mindray Medical
International Limited (Mindray) announced the completion of its
acquisition of ZONARE Medical Systems, Inc. (ZONARE), pursuant to
the terms of the previously announced definitive agreement entered
into on June 12, 2013. Under the
agreement, Mindray acquired ZONARE for a total purchase price of
$101.7 million in cash, as adjusted
for working capital at the closing date. Mindray expects that the
combined business will benefit from ZONARE's strong innovative
R&D capability and direct sales and service network in the
high-end ultrasound market together with Mindray's efficient
engineering, extensive distribution channels, and broad production
platforms. The Full Research Report on Mindray Medical
International Limited - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge
at: [http://www.investorsreports.com/report/2013-07-18/MR]
--
CareFusion Corporation Research
Report
On July 16, 2013, CareFusion
Corporation (CareFusion) announced that it was one of the first
groups of health IT products providers that has received
certification under a new healthcare certification program launched
by IHE USA and ICSA Labs. The
Company informed that under the certification program, the products
met rigorous testing requirements for security and
interoperability. CareFusion also stated that the certification
builds on specifications of the Federal Office of the National
Coordinator for Health IT, giving purchasers of health IT products
independent third-party verification that products are suitable for
health data exchange and function as intended. The certification
program will expand by utilizing virtual testing events in fall of
2013, leading up to the 2014 IHE North American Connectathon to be
held from January 27 to January 31,
2014 in Chicago. The Full
Research Report on CareFusion Corporation - including full detailed
breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.investorsreports.com/report/2013-07-19/CFN]
--
DENTSPLY International Inc. Research
Report
On July 15, 2013, DENTSPLY
International Inc. (DENTSPLY) announced that it will release its Q2
2013 earnings results on August 1,
2013 at 7:00 a.m. ET.
Following the press release, the Company will host a conference
call with a live webcast to discuss the financial results. In its
Q1 2013 earnings results release, Bret
Wise, Chairman and CEO of DENTSPLY commented on the
Company's full-year 2013 outlook, "Looking forward, we believe that
we have opportunities to accelerate growth in both sales and
earnings as the year progresses. Given the current market
environment and currency exchange rates, we are revising our
expectations for adjusted earnings per share for 2013 to a range of
$2.33 to $2.43." The Full Research
Report on DENTSPLY International Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.investorsreports.com/report/2013-07-19/XRAY]
----
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by a CFA. However, we are only
human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us
at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Equity News Network. An outsourced research services provider has,
through Chartered Financial Analysts, only reviewed the information
provided by Equity News Network in this article or report according
to the Procedures outlined by Equity News Network. Equity News
Network is not entitled to veto or interfere in the application of
such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as
to the accuracy or completeness or fitness for a purpose
(investment or otherwise), of the information provided in this
document. This information is not to be construed as personal
financial advice. Readers are encouraged to consult their personal
financial advisor before making any decisions to buy, sell or hold
any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may
be occasioned at the time of printing of this document or any
error, mistake or shortcoming. No liability is accepted by Equity
News Network whatsoever for any direct, indirect or consequential
loss arising from the use of this document. Equity News Network
expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Equity News Network
does not (1) guarantee the accuracy, timeliness, completeness or
correct sequencing of the information, or (2) warrant any results
from use of the information. The included information is subject to
change without notice.
SOURCE Investors' Reports